PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 266 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,002,855 | +679.3% | 51,874 | +972.4% | 0.23% | +1065.0% |
| Q3 2022 | $257,000 | -42.9% | 4,837 | -18.0% | 0.02% | -47.4% |
| Q1 2022 | $450,000 | -1.1% | 5,902 | -22.0% | 0.04% | -5.0% |
| Q4 2021 | $455,000 | -46.3% | 7,565 | -50.0% | 0.04% | -60.4% |
| Q3 2021 | $847,000 | +19.3% | 15,124 | +29.2% | 0.10% | -7.3% |
| Q2 2021 | $710,000 | – | 11,708 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |